An Investigation Into Bone Micro-architecture in Women With Type 2 Diabetes
A Cross-sectional Comparison of Bone Micro-architecture in Postmenopausal Women With Type 2 Diabetes and Age-matched Controls
1 other identifier
observational
60
1 country
1
Brief Summary
The number of people with type 2 diabetes is growing. This puts a lot of pressure on the health care systems. Type 2 diabetes is often associated with health problems, like poor eyesight, muscle coordination, muscle strength, and blood flow. Poor bone health may also be a concern for people with type 2 diabetes. A large proportion of people with type 2 diabetes will break a bone in their lifetime. The risk of this happening in older people with type 2 diabetes is greater than the risk in older people without diabetes. Fracturing a bone can be very painful, and lead to serious consequences, especially if the individual experiences a hip fracture. The elevated fracture risk, seen in those with type 2 diabetes, is puzzling because people with type 2 diabetes often appear to have normal, healthy bones compared to people of the same age without diabetes. Bone micro-structure, which is not assessed by traditional bone densitometry systems (ie: DXA) contributes to overall bone strength. The hypothesis of this study is that bone micro-structure is of poorer quality (reduced trabecular thickness, increased trabecular spacing) in postmenopausal women with type 2 diabetes, compared to age-matched control participants.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Sep 2008
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2008
CompletedFirst Submitted
Initial submission to the registry
September 21, 2009
CompletedFirst Posted
Study publicly available on registry
September 23, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2011
CompletedJune 19, 2012
June 1, 2012
3.2 years
September 21, 2009
June 17, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
1 Tesla peripheral MRI assessment at non dominant distal radius: Trabecular bone micro-architecture parameters Tb.Th, Tb.Sp, Tb.N, BV/TV, bone CSA, marrow space
MRI scan complete approximately 1 month after participant is enrolled
Secondary Outcomes (1)
Calcium, vitamin D and vitamin K dietary intakes; TUG (sec); grip strength; DXA assessment of hip, lumbar spine, total body; physical activity
baseline
Study Arms (2)
Controls
female; \>65 years old; BMI \>25kg/m2; postmenopausal \>5 yrs; NO clinical diagnosis of type 2 diabetes for \>5 years (according to Canadian Diabetes Association criteria)
Type 2 Diabetes
female; \>65 years old; BMI \>25kg/m2; postmenopausal \>5 yrs; clinical diagnosis of type 2 diabetes for \>5 years (according to Canadian Diabetes Association criteria)
Eligibility Criteria
female; \>65 years old; BMI \>25kg/m2; postmenopausal \>5 yrs
You may qualify if:
- female
- \>= 65 years old
- postmenopausal for \> 5 years (WHO definition of menopause)
You may not qualify if:
- currently taking osteoporosis related medication (HRT, SERM, bisphosphonate, PTH, calcitonin, fluoride)
- had cancer in past 10 years, likely to metastasize to bone (ie: breast, lung)
- have intrinsic bone disease (ie: Paget's Disease, Cushings syndrome)
- have untreated malabsorption syndrome (ie: Celiac Disease)
- renal insufficiency (CrCl \<30ml/min)
- hyperparathyroidism, hypoparathyroidism
- chronic systemic glucocorticosteroid use \> 3mos, dose\>2.5mg daily
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hamilton Health Sciences Corporationlead
- Canadian Institutes of Health Research (CIHR)collaborator
- McMaster Universitycollaborator
Study Sites (1)
McMaster University
Hamilton, Ontario, L8N 3Z5, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 21, 2009
First Posted
September 23, 2009
Study Start
September 1, 2008
Primary Completion
December 1, 2011
Study Completion
December 1, 2011
Last Updated
June 19, 2012
Record last verified: 2012-06